Incannex Healthcare Inc. SEC filings IXHL

Incannex Healthcare Inc. has 266 filings in SEC EDGAR's recent list, going back to Aug 17, 2021. Its latest annual report, Form ARS, was filed on Oct 28, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 15, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 9, 2026 (regulation fd disclosure). The company's fiscal year ends on June 30.

Form Description Filed Period
DEFA14A Additional proxy material Oct 28, 2026 —
DEF 14A Proxy statement Oct 28, 2026 Dec 17, 2026
DEFA14A Additional proxy material Dec 18, 2025 —
DEFA14A Additional proxy material Dec 16, 2025 —
DEFA14A Additional proxy material Oct 27, 2025 —
DEF 14A Proxy statement Oct 27, 2025 Dec 18, 2025
DEFA14A Additional proxy material May 16, 2025 —
DEF 14A Proxy statement Apr 28, 2025 May 27, 2025
PRE 14A Preliminary proxy statement Mar 18, 2025 Mar 18, 2025
DEF 14A Proxy statement Nov 12, 2024 Dec 11, 2024
PRE 14A Preliminary proxy statement Oct 31, 2024 Oct 31, 2024

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IXHL (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Norwest Nsw
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1873875
Former names
Incannex Healthcare Ltd (until Nov 29, 2023)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.